Maire F, Hammel P, Terris B, et al. Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma. Gut. 2002;51:717–22.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yogi T, Hijioka S, Imaoka H, et al. Risk factors for postoperative recurrence of intraductal papillary mucinous neoplasms of the pancreas based on a long-term follow-up study: proposals for follow-up strategies. J Hepato-Bil Pancreat Sci. 2015;22:757–65.

Article  Google Scholar 

Ohtsuka T, Fernandez-Del Castillo C, Furukawa T, et al. International evidence-based Kyoto guidelines for the management of intraductal papillary mucinous neoplasm of the pancreas. Pancreatology. 2024;24:255–70.

Article  CAS  PubMed  Google Scholar 

Elta GH, Enestvedt BK, Sauer BG, et al. ACG clinical guideline: diagnosis and management of pancreatic cysts. Am J Gastroenterol. 2018;113:464–79.

Article  PubMed  Google Scholar 

European Study Group on Cystic Tumours of the Pancreas. European evidence-based guidelines on pancreatic cystic neoplasms. Gut. 2018;67:789–804.

Article  Google Scholar 

Tanaka M, Fernández-Del Castillo C, Kamisawa T, et al. Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas. Pancreatology. 2017;17:738–53.

Article  PubMed  Google Scholar 

Yonezawa S, Horinouchi M, Osako M, et al. Gene expression of gastric type mucin (MUC5AC) in pancreatic tumors: its relationship with the biologic behavior of the tumor. Pathol Int. 1999;49:45–54.

Article  CAS  PubMed  Google Scholar 

Furukawa T, Klöppel G, Adsay NV, et al. Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study. Virchows Arch. 2005;447:794–9.

Article  PubMed  Google Scholar 

Basturk O, Hong SM, Wood LD, et al. A revised classification system and recommendations from the Baltimore consensus meeting for neoplastic precursor lesions in the pancreas. Am J Surg Pathol. 2015;39:1730–41.

Article  PubMed  PubMed Central  Google Scholar 

Furukawa T, Hatori T, Fujita I, et al. Prognostic relevance of morphological types of intraductal papillary mucinous neoplasms of the pancreas. Gut. 2011;60:509–16.

Article  PubMed  Google Scholar 

Mino-Kenudson M, Fernández-del Castillo C, Baba Y, et al. Prognosis of invasive intraductal papillary mucinous neoplasm depends on histological and precursor epithelial subtypes. Gut. 2011;60:1712–20.

Article  PubMed  Google Scholar 

Distler M, Kersting S, Niedergethmann M, et al. Pathohistological subtype predicts survival in patients with intraductal papillary mucinous neoplasm (IPMN) of the pancreas. Ann Surg. 2013;258:324–30.

Article  PubMed  Google Scholar 

Tamura K, Ohtsuka T, Ideno N, et al. Treatment strategy for main-duct intraductal papillary mucinous neoplasms of the pancreas based on the assessment of recurrence in the remnant pancreas after resection: a retrospective review. Ann Surg. 2014;259:360–8.

Article  PubMed  Google Scholar 

Hirono S, Shimizu Y, Ohtsuka T, et al. Recurrence patterns after surgical resection of intraductal papillary mucinous neoplasm (IPMN) of the pancreas; a multicenter, retrospective study of 1074 IPMN patients by the Japan Pancreas Society. J Gastroenterol. 2020;55:86–99.

Article  CAS  PubMed  Google Scholar 

Kang MJ, Jang JY, Lee KB, et al. Long-term prospective cohort study of patients undergoing pancreatectomy for intraductal papillary mucinous neoplasm of the pancreas: implications for postoperative surveillance. Ann Surg. 2014;260:356–63.

Article  PubMed  Google Scholar 

Ohtsuka T, Kono H, Tanabe R, et al. Follow-up study after resection of intraductal papillary mucinous neoplasm of the pancreas; special references to the multifocal lesions and development of ductal carcinoma in the remnant pancreas. Am J Surg. 2012;204:44–8.

Article  PubMed  Google Scholar 

Majumder S, Philip NA, Singh Nagpal SJ, et al. High-grade dysplasia in resected main-duct intraductal papillary mucinous neoplasm (MD-IPMN) is associated with an increased risk of subsequent pancreatic cancer. Am J Gastroenterol. 2019;114:524–9.

Article  PubMed  Google Scholar 

Pea A, Yu J, Rezaee N, et al. Targeted DNA sequencing reveals patterns of local progression in the pancreatic remnant following resection of intraductal papillary mucinous neoplasm (IPMN) of the pancreas. Ann Surg. 2017;266:133–41.

Article  PubMed  Google Scholar 

Miyasaka Y, Ohtsuka T, Tamura K, et al. Predictive factors for the metachronous development of high-risk lesions in the remnant pancreas after partial pancreatectomy for intraductal papillary mucinous neoplasm. Ann Surg. 2016;263:1180–7.

Article  PubMed  Google Scholar 

Nagai K, Mizukami Y, Omori Y, et al. Metachronous intraductal papillary mucinous neoplasms disseminate via the pancreatic duct following resection. Mod Pathol. 2020;33:971–80.

Article  CAS  PubMed  Google Scholar 

Shimizu Y, Hijioka S, Hirono S, et al. New model for predicting malignancy in patients with intraductal papillary mucinous neoplasm. Ann Surg. 2020;272:155–62.

Article  PubMed  Google Scholar 

Kin T, Shimizu Y, Hijioka S, et al. A comparative study between computed tomography and endoscopic ultrasound in the detection of a mural nodule in intraductal papillary mucinous neoplasm—Multicenter observational study in Japan. Pancreatology. 2023;23:550–5.

Article  PubMed  Google Scholar 

Tanaka M, Fernández-del Castillo C, Adsay V, et al. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology. 2012;12:183–97.

Article  PubMed  Google Scholar 

Tanaka M, Chari S, Adsay V, et al. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology. 2006;6:17–32.

Article  PubMed  Google Scholar 

Adsay V, Mino-Kenudson M, Furukawa T, et al. Pathologic evaluation and reporting of intraductal papillary mucinous neoplasms of the pancreas and other tumoral intraepithelial neoplasms of pancreatobiliary tract: recommendations of Verona consensus meeting. Ann Surg. 2016;263:162–77.

Article  PubMed  Google Scholar 

Hirono S, Kawai M, Okada KI, et al. Long-term surveillance is necessary after operative resection for intraductal papillary mucinous neoplasm of the pancreas. Surgery. 2016;160:306–17.

Article  PubMed  Google Scholar 

Miyasaka Y, Ohtsuka T, Matsuda R, et al. High-risk lesions in the remnant pancreas: fate of the remnant pancreas after pancreatic resection for pancreatic cancer and intraductal papillary mucinous neoplasms. Surg Today. 2020;50:832–40.

Article  PubMed  Google Scholar 

Omori Y, Ono Y, Tanino M, et al. Pathways of progression from intraductal papillary mucinous neoplasm to pancreatic ductal adenocarcinoma based on molecular features. Gastroenterology. 2019;156:647-661.e2.

Article  CAS  PubMed  Google Scholar 

Matsuda R, Miyasaka Y, Ohishi Y, et al. Concomitant intraductal papillary mucinous neoplasm in pancreatic ductal adenocarcinoma is an independent predictive factor for the occurrence of new cancer in the remnant pancreas. Ann Surg. 2020;271:941–8.

Article  PubMed  Google Scholar 

Omori Y, Ono Y, Morikawa T, et al. Serine/threonine kinase 11 plays a canonical role in malignant progression of KRAS-mutant and GNAS-wild-type intraductal papillary mucinous neoplasms of the pancreas. Ann Surg. 2023;277:e384–95.

Article  PubMed  Google Scholar 

Hara T, Ikebe D, Odaka A, et al. Preoperative histologic subtype classification of intraductal papillary mucinous neoplasms (IPMN) by pancreatic juice cytology with MUC stain. Ann Surg. 2013;257:1103–11.

Article  PubMed  Google Scholar 

Kobayashi T, Omori Y, Ono Y, et al. Pathways for the development of multiple epithelial types of intraductal papillary mucinous neoplasm of the pancreas. J Gastroenterol. 2021;56:581–92.

Article  CAS  PubMed  Google Scholar